IBDX Performance — iShares iBonds Dec 2032 Term Corporate ETF
Data updated: 2026-09-25
IBDX returned −0.24% year to date and +3.30% over one year to Jul 2026. The annualised 3-year return is +5.46%. The fund beat its Intermediate Corporate Bond category average: $100 invested three years ago grew to $117, against $116 for the category, and to $103 over one year, against $103. Volatility over the past three years was 6.59% a year. In the 12 months to Jul 2026 the fund took in a net $571.2M, and assets reached $1.72B.
IBDX Growth of $100
What $100 invested in iShares iBonds Dec 2032 Term Corporate ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Intermediate Corporate Bond category average over the same months.
| Period | IBDX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $103 | $103 |
| 3 years (Aug 2023 – Jul 2026) | $117 | $116 |
| Since data start (Jun 2022 – Jul 2026) | $121 | $116 |
IBDX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −0.24% |
| 1 year | +3.30% |
| 3 years (annualised) | +5.46% |
IBDX Annual Returns
Calendar-year total returns of iShares iBonds Dec 2032 Term Corporate ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | −0.24% |
| 2025 | +9.10% |
| 2024 | +2.56% |
| 2023 | +9.30% |
| 2022 (Jun–Dec) | −1.09% |
IBDX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.3% | +1.3% | −1.9% | +0.5% | +0.3% | +0.1% | −0.8% | — | — | — | — | — |
| 2025 | +0.5% | +2.0% | +0.1% | +0.4% | +0.3% | +1.7% | +0.4% | +1.3% | +1.1% | +0.3% | +0.8% | 0.0% |
| 2024 | −0.3% | −1.7% | +1.4% | −2.5% | +1.9% | +0.8% | +2.6% | +1.6% | +1.7% | −2.4% | +1.4% | −1.7% |
| 2023 | +4.5% | −3.6% | +3.5% | +0.9% | −1.5% | +0.1% | +0.3% | −0.7% | −3.0% | −2.1% | +6.6% | +4.5% |
| 2022 | — | — | — | — | — | +0.8% | +4.3% | −4.0% | −5.8% | −0.6% | +5.4% | −0.9% |
IBDX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 6.59%
- 3-year Sharpe ratio: 0.15 (vs 4.5% risk-free rate)
- Best month: +6.60% (Nov 2023)
- Worst month: −3.02% (Sep 2023)
IBDX Fund Flows
Monthly money in and out of iShares iBonds Dec 2032 Term Corporate ETF, from SEC Form N-PORT.
- 12-month net flow: $571.2M
- 12-month gross sales (incl. reinvestments): $646.2M
- Sales ÷ redemptions: 8.61×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $37.4M | $0 | $37.4M |
| Jun 2026 | $36.4M | $0 | $36.4M |
| May 2026 | $27.6M | $0 | $27.6M |
| Apr 2026 | $20.3M | $7.6M | $12.7M |
| Mar 2026 | $35.6M | $0 | $35.6M |
| Feb 2026 | $43.5M | $0 | $43.5M |
| Jan 2026 | $58.7M | $0 | $58.7M |
| Dec 2025 | $158.3M | $0 | $158.3M |
| Nov 2025 | $21.7M | $39.5M | −$17.8M |
| Oct 2025 | $80.9M | $7.7M | $73.2M |
| Sep 2025 | $61.3M | $20.3M | $41.0M |
| Aug 2025 | $64.6M | $0 | $64.6M |
IBDX Assets Under Management
Net assets of iShares iBonds Dec 2032 Term Corporate ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $1.72B |
| 2026-04-30 | $1.64B |
| 2026-01-31 | $1.57B |
| 2025-10-31 | $1.37B |
| 2025-07-31 | $1.18B |
| 2025-04-30 | $1.04B |
| 2025-01-31 | $959.60M |
| 2024-10-31 | $850.87M |
| 2024-07-31 | $720.30M |
| 2024-04-30 | $593.11M |
| 2024-01-31 | $463.75M |
| 2023-10-31 | $244.51M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.